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It’s now cheaper to print color figures in KI
Have you been concerned in the past about the cost of print-
ing color figures in Kidney International (KI)? KI has listened 
to your concerns and is now offering permanently reduced 
pricing for color figures—a flat fee of $500 per printed page, 
no matter how many color figures are on a page. This pricing 
is more affordable for authors and competitive with other top 
scientific journals. We want to make it easier for authors to 
publish the color figures that demonstrate important scien-
tific findings, and our new pricing reflects our commitment to 
achieving this goal.
nature publishing group
LECT2, a new amyloid 
component
Some patients with amyloidosis have 
deposits that do not react to antibodies 
that recognize the traditional causes of 
amyloidosis, such as immunoglobulin 
light chains-λ and -κ and serum amyloid 
A. These deposits react with Congo red; 
hence, it is obvious that there are additional 
proteins that have the classic β-sheets that 
can make amyloid deposits. As they report 
in this issue, Larsen et al. isolated amyloid 
fibrils from such patients, subjected them 
to chemical analysis, and found leuko-
cyte chemotactic factor 2 (LECT2) to be 
the protein responsible for these deposits. 
From a large referral base with 285 renal 
amyloid samples, 31 could not be classi-
fied by the classic causes. Tandem mass 
spectrometry of these 31 samples showed 
that seven of them were LECT2, which 
was confirmed by immunohistochemistry. 
These deposits also stained for Congo red 
and, in most cases, had distinctive morpho-
logical features with diffuse involvement of 
the interstitium, arteries, and glomeruli. 
See page 816.
Regulatory T cells are 
protective in ischemic 
preconditioning
One of the most popular models of acute 
tubular necrosis is produced by induction 
of ischemia. Numerous studies have found 
that when renal blood flow is re-established, 
this reperfusion produces a large number of 
changes that, in fact, may be causal to the 
acute kidney injury. Remarkably, a short 
period of ischemia seems to protect the 
kidney from injury induced by a subse-
quent ischemia. As they report in this issue, 
Kinsey et al. used this so-called ischemic 
preconditioning, which is partially medi-
ated by T regulatory (Treg) lymphocytes 
that suppress immune responses. The 
authors found that this maneuver inhib-
ited the accumulation of neutrophils and 
macrophages, tubular necrosis, and loss 
of kidney function caused by a subsequent 
ischemia/reperfusion injury. Depletion of 
the Treg cells with an antibody reversed the 
beneficial effect of preconditioning on kid-
ney neutrophil accumulation and partially 
inhibited the functional and histological 
protection of preconditioning. Further, 
adoptive transfer of Treg cells in naive mice, 
before ischemia/reperfusion, mimicked the 
protective and anti-inflammatory effects of 
ischemic preconditioning on the kidney. 
These studies show that Treg cells are criti-
cal in protecting the kidney in this model of 
ischemic preconditioning.  See page 771.
Tubulointerstitial 
disease in lupus 
nephritis
The system for classifying patients with 
lupus nephritis provided by the Inter-
national Society of Nephrology and the 
Renal Pathology Society in 2003 rapidly 
became the gold standard in classification 
of the disease, and the basis for many stud-
ies and therapeutic decisions. However, 
the classification system was based entirely 
on glomerular lesions, even though it is 
well known that interstitial disease occurs 
in lupus nephritis. Yu et al. analyzed the 
tubulointerstitial lesions in patients with 
lupus nephritis. They found that among 313 
patients, the 170 with class IV had severe 
interstitial inflammatory-cell infiltration, 
tubular atrophy, and interstitial fibrosis. 
Tubulointerstitial disease was present in 
almost all types of lupus glomerular disease, 
to varying degrees. These important stud-
ies show that the extent of tubulointerstitial 
lesions needs to be taken into account when 
the renal outcome in patients with lupus 
nephritis is estimated. See page 820.
